ARTICLE | Company News
Biotecnol S.A., INSERM, Hopitaux Universitaires de Strasbourg, Universite Louis Pasteur deal
February 9, 2009 8:00 AM UTC
The institutions granted Biotecnol an exclusive, worldwide license to develop and commercialize IP covering parathyroid hormone-related protein (PTHrP) antagonists to treat renal cell carcinoma (RCC)....